Business Context and Reporting Period
Company: Flexible Solutions International Inc. (FSI)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2025
Business Overview: FSI develops and markets biodegradable polymers (TPAs) for the oil, gas, and agriculture industries, as well as energy and water conservation products (EWCP) for pools and irrigation. The company operates through two primary segments: Energy and Water Conservation Products (EWCP) and Biodegradable Polymers (BCPA).
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|---|
| Total Sales | $10,556,291 | $9,314,937 | $29,397,115 | $29,068,548 |
| Gross Profit | $2,523,775 | $3,806,816 | $9,860,605 | $10,566,278 |
| Gross Margin | 23.9% | 40.9% | 33.5% | 36.4% |
| Operating Income | $311,303 | $1,913,950 | $3,539,260 | $4,650,693 |
| Net Income (Consolidated) | $386,688 | $1,092,348 | $2,267,881 | $3,040,990 |
| Net Income Attributable to FSI | $(503,358) | $611,858 | $1,247,820 | $2,358,880 |
| Diluted EPS (Attributable to FSI) | $(0.04) | $0.05 | $0.09 | $0.19 |
| Cash Provided by Operating Activities (YTD) | $6,757,198 (2025) vs $7,787,989 (2024) | |||
| Total Assets | $58,352,786 (Sep 30, 2025) vs $59,968,579 (Dec 31, 2024) | |||
| Total Debt (Current + Long Term) | $7,636,655 (Sep 30, 2025) vs $10,811,807 (Dec 31, 2024) | |||
| Working Capital | $21,780,752 (Sep 30, 2025) |
Material Changes vs. Prior Period
- Revenue Mix: Q3 2025 saw a 13.3% increase in total sales compared to Q3 2024, driven by a 15.5% increase in TPA product sales. However, EWCP product sales declined 55.9% due to decreased customer orders. YTD 2025 revenue was flat compared to 2024, as a $2.5 million one-time research and development service contract offset declines in both TPA and EWCP product sales.
- Profitability: Gross margin contracted significantly in Q3 2025 (23.9%) compared to Q3 2024 (40.9%) due to increased costs associated with scaling new products. Operating income dropped 83.7% in Q3 2025 compared to the prior year.
- Non-Controlling Interests (NCI): While consolidated net income was positive, net income attributable to FSI shareholders was negative in Q3 2025 ($(503,358)) due to a significant allocation of income to non-controlling interests ($890,046). This contrasts with Q3 2024, where FSI shareholders received $611,858.
- Debt Reduction: Total debt decreased by approximately $3.2 million year-over-year, primarily due to repayments of short-term lines of credit and long-term debt. The company paid off a $2.18 million mortgage on a building sold in October 2025 (subsequent event).
- Investment Activity: The company received a $500,000 return on investment from Trio Opportunity Corp. in Q3 2025. Unlike 2024, there were no significant one-time gains or losses from the sale of the Florida-based LLC equity stake.
Guidance, Outlook, and Risks
- Management Commentary: Management attributes the decline in EWCP sales to reduced customer orders and the decline in TPA sales (YTD) to similar factors, partially offset by the successful completion of a specific R&D project. Increased operating expenses were driven by building repairs, higher professional fees for tax/audit, and new product development.
- Liquidity: The company reports sufficient cash resources to meet future commitments for the coming year. Working capital remains strong at $21.8 million.
- Key Risks:
- Customer Concentration: Three customers accounted for 65% of product sales in Q3 2025 and 54% YTD 2025.
- Raw Material Costs: Reliance on aspartic acid imported from China, subject to crude oil price fluctuations and potential new tariffs.
- Market Conditions: Performance is tied to oil and gas industry activity and drought conditions affecting agricultural demand.
- Interest Rates: Exposure to variable interest rates on lines of credit and mortgages.
- Subsequent Event: In October 2025, the company sold a building and land owned by 317 Mendota for $3.75 million, using proceeds to pay off a $2.18 million mortgage.
Investor Verification Checklist
- NCI Impact: Verify the sustainability of the high non-controlling interest allocation ($890k in Q3) and its impact on future per-share earnings.
- Customer Concentration: Assess the risk associated with the top three customers representing 65% of Q3 sales.
- Gross Margin Compression: Investigate the specific cost drivers behind the drop in gross margin from 40.9% to 23.9% in Q3 2025.
- One-Time Revenue: Confirm the recurring nature of the $2.5 million R&D service revenue recognized YTD 2025.
- Debt Covenants: Review the terms of the renewed lines of credit with Stock Yards Bank and Trust to ensure compliance with financial ratios.